Dorine de Jong

ORCID: 0000-0003-4366-9145
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Phagocytosis and Immune Regulation
  • Virus-based gene therapy research
  • Biomedical and Engineering Education
  • Erythrocyte Function and Pathophysiology
  • Radiopharmaceutical Chemistry and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Prostate Cancer Treatment and Research
  • Medical Imaging Techniques and Applications
  • Glioma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Cell death mechanisms and regulation
  • Integrated Circuits and Semiconductor Failure Analysis
  • Prostate Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Medical Imaging and Pathology Studies
  • Cytomegalovirus and herpesvirus research
  • HER2/EGFR in Cancer Research
  • Biomedical Ethics and Regulation
  • Viral Infectious Diseases and Gene Expression in Insects
  • Immunotherapy and Immune Responses
  • Lymphoma Diagnosis and Treatment
  • Transplantation: Methods and Outcomes
  • Autophagy in Disease and Therapy

RefleXion Medical (United States)
2023-2025

Columbia University Irving Medical Center
2024

Memorial Sloan Kettering Cancer Center
2021-2023

Université Paris-Saclay
2017-2018

Institut Gustave Roussy
2017-2018

Inserm
2017

Abstract Even though cell death modalities elicited by anticancer chemotherapy and radiotherapy have been extensively studied, the ability of treatments to induce non-cell-autonomous has never investigated. By means multispectral imaging flow-cytometry-based technology, we analyzed lethal fate cancer cells that were treated with conventional agents co-cultured untreated cells, observing can simultaneously trigger cell-autonomous in cells. After ionizing radiation, oxaliplatin, or cisplatin...

10.1038/s41419-018-0747-y article EN cc-by Cell Death and Disease 2018-06-18

e12575 Background: SCINTIX biology-guided radiotherapy (BgRT) uses F18-FDG emissions from lung and bone tumors to direct beamlets almost in real-time. Expanding BgRT indications with more specific radiotracers like F18-FES holds therapeutic promise. This study investigates PET imaging metrics estrogen receptor positive (ER+) breast cancer lesions for potential use. Methods: Ten FES PET/CT scans patients 16 ER+ total were retrospectively selected one institution. Eight of these also underwent...

10.1200/jco.2025.43.16_suppl.e12575 article EN Journal of Clinical Oncology 2025-05-28

Purpose/objective(s) Bridging radiation therapy (bRT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell for large B-cell lymphoma (LBCL). It unknown how the extent of cytoreduction during bRT impacts outcomes. Materials/methods We retrospectively reviewed patients with LBCL treated followed by CAR therapy. Metabolic tumor volume (MTV), maximum standardized uptake value (SUV max ), SUV mean , and total lesion glycolysis (TLG) were extracted from...

10.3389/fimmu.2024.1419788 article EN cc-by Frontiers in Immunology 2024-10-01

[18F]-FDG positron emission tomography with computed (PET/CT) imaging is widely used to enhance the quality of care in patients diagnosed cancer. Furthermore, it holds potential offer insight into synergic effect combining radiation therapy (RT) immuno-oncological (IO) agents. This achieved by evaluating treatment responses both at RT and distant tumor sites, thereby encompassing phenomenon known as abscopal effect. In this context, PET/CT can play an important role establishing timelines...

10.3390/cancers15215179 article EN Cancers 2023-10-27
Coming Soon ...